Expanded STELARA® indication seeks to treat children two years of age and older with moderately to severely active ulcerative colitis, based on Week 52 data from UNIFI Jr HORSHAM, Pa. –… Read More
ELAHERE® receives a positive recommendation by Canada’s Drug Agency (CDAAMC) ELAHERE® was submitted for reimbursement review 180 days prior to Health Canada’s approval in line with CDA-AMC’s new Target Zero… Read More
New collaboration aims to reduce cardiac MRI wait times and expand access to advanced heart diagnostics in urban and remote communities Providence Health Care Ventures (PHC Ventures) and Ventripoint Diagnostics Ltd…. Read More
The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG… Read More
EDMONTON, AB – Strengthening international partnerships, GlycoNet and Spain-based CIC bioGUNE have signed a Memorandum of Understanding (MOU) to deepen collaboration in glycomics—the study of complex sugars that coat our… Read More
